132 related articles for article (PubMed ID: 35636767)
21. Matrix metalloproteinase (MMP-2, -9) and tissue inhibitor (TIMP-1, -2) activity in tear samples of pediatric type 1 diabetic patients: MMPs in tear samples from type 1 diabetes.
Symeonidis C; Papakonstantinou E; Galli A; Tsinopoulos I; Mataftsi A; Batzios S; Dimitrakos SA
Graefes Arch Clin Exp Ophthalmol; 2013 Mar; 251(3):741-9. PubMed ID: 23254483
[TBL] [Abstract][Full Text] [Related]
22. Imbalance between matrix metalloproteinases (MMP-9 and MMP-2) and tissue inhibitors of metalloproteinases (TIMP-1 and TIMP-2) in acute respiratory distress syndrome patients.
Lanchou J; Corbel M; Tanguy M; Germain N; Boichot E; Theret N; Clement B; Lagente V; Malledant Y
Crit Care Med; 2003 Feb; 31(2):536-42. PubMed ID: 12576963
[TBL] [Abstract][Full Text] [Related]
23. Prevalence of vascular-endothelial growth factor, matrix metalloproteinases and tissue inhibitors of metalloproteinases in primary breast cancer.
Jobim FC; Xavier NL; Uchoa DM; Cruz DB; Saciloto M; Chemello N; Schwartsmann G
Braz J Med Biol Res; 2009 Oct; 42(10):979-87. PubMed ID: 19787153
[TBL] [Abstract][Full Text] [Related]
24. Expression of matrix metalloproteinases (MMP-2 and -9) and their inhibitors (TIMP-1 and -2) in prostate cancer tissue.
Brehmer B; Biesterfeld S; Jakse G
Prostate Cancer Prostatic Dis; 2003; 6(3):217-22. PubMed ID: 12970724
[TBL] [Abstract][Full Text] [Related]
25. Matrix metalloproteinase and tissue inhibitors of metalloproteinase secretion by haematopoietic and stromal precursors and their production in normal and leukaemic long-term marrow cultures.
Marquez-Curtis LA; Dobrowsky A; Montaño J; Turner AR; Ratajczak J; Ratajczak MZ; Janowska-Wieczorek A
Br J Haematol; 2001 Dec; 115(3):595-604. PubMed ID: 11736941
[TBL] [Abstract][Full Text] [Related]
26. Altered matrix metalloproteinases and tissue inhibitors of metalloproteinases in embryos from diabetic rats during early organogenesis.
Higa R; Kurtz M; Capobianco E; Martínez N; White V; Jawerbaum A
Reprod Toxicol; 2011 Dec; 32(4):449-62. PubMed ID: 21963884
[TBL] [Abstract][Full Text] [Related]
27. Matrix metalloproteinase imbalance in inguinal hernia formation.
Antoniou GA; Tentes IK; Antoniou SA; Simopoulos C; Lazarides MK
J Invest Surg; 2011; 24(4):145-50. PubMed ID: 21675849
[TBL] [Abstract][Full Text] [Related]
28. Amlodipine and Atorvastatin Improved Hypertensive Cardiac Remodeling through Regulation of MMPs/TIMPs in SHR Rats.
Lu J; Hao J; Du H; Xiao B; Li Y; Yang X; Cui W
Cell Physiol Biochem; 2016; 39(1):47-60. PubMed ID: 27322513
[TBL] [Abstract][Full Text] [Related]
29. Prognostic significance of MMP-9 and TIMP-1 serum and tissue expression in breast cancer.
Wu ZS; Wu Q; Yang JH; Wang HQ; Ding XD; Yang F; Xu XC
Int J Cancer; 2008 May; 122(9):2050-6. PubMed ID: 18172859
[TBL] [Abstract][Full Text] [Related]
30. Expression of matrix metalloproteinases 2 and 9 and tissue inhibitors of matrix metalloproteinases 2 and 1 in the glomeruli of human glomerular diseases: the results of studies using immunofluorescence, in situ hybridization, and immunoelectron microscopy.
Sekiuchi M; Kudo A; Nakabayashi K; Kanai-Azuma M; Akimoto Y; Kawakami H; Yamada A
Clin Exp Nephrol; 2012 Dec; 16(6):863-74. PubMed ID: 22614167
[TBL] [Abstract][Full Text] [Related]
31. Differential expression profiling of matrix metalloproteinases and tissue inhibitors of metalloproteinases in females with or without pelvic organ prolapse.
Wang X; Li Y; Chen J; Guo X; Guan H; Li C
Mol Med Rep; 2014 Oct; 10(4):2004-8. PubMed ID: 25110112
[TBL] [Abstract][Full Text] [Related]
32. [The expression of matrix metalloproteinases and their tissue inhibitors in pleomorphic adenoma].
Chen Y; Tian K; Geng N; Yang MZ; Zhang WP
Zhonghua Kou Qiang Yi Xue Za Zhi; 2005 Jan; 40(1):58-61. PubMed ID: 15774155
[TBL] [Abstract][Full Text] [Related]
33. HIV-1 gp120 upregulates matrix metalloproteinases and their inhibitors in a rat model of HIV encephalopathy.
Louboutin JP; Reyes BA; Agrawal L; Van Bockstaele EJ; Strayer DS
Eur J Neurosci; 2011 Dec; 34(12):2015-23. PubMed ID: 22092673
[TBL] [Abstract][Full Text] [Related]
34. Endometrial tumor invasiveness is related to metalloproteinase 2 and tissue inhibitor of metalloproteinase 2 expressions.
Graesslin O; Cortez A; Uzan C; Birembaut P; Quereux C; Daraï E
Int J Gynecol Cancer; 2006; 16(5):1911-7. PubMed ID: 17009991
[TBL] [Abstract][Full Text] [Related]
35. Relationship between matrix metalloproteinases/tissue inhibitors of matrix metalloproteinases systems and autoantibody patterns in systemic sclerosis.
Montagnana M; Volpe A; Lippi G; Caramaschi P; Salvagno GL; Biasi D; Bambara LM; Guidi GC
Clin Biochem; 2007 Aug; 40(12):837-42. PubMed ID: 17493602
[TBL] [Abstract][Full Text] [Related]
36. rd1 mouse retina shows imbalance in cellular distribution and levels of TIMP-1/MMP-9, TIMP-2/MMP-2 and sulfated glycosaminoglycans.
Ahuja S; Ahuja P; Caffé AR; Ekstrom P; Abrahamson M; van Veen T
Ophthalmic Res; 2006; 38(3):125-36. PubMed ID: 16374054
[TBL] [Abstract][Full Text] [Related]
37. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in the aqueous humour of patients with primary angle closure glaucoma - a quantitative study.
Nga AD; Yap SL; Samsudin A; Abdul-Rahman PS; Hashim OH; Mimiwati Z
BMC Ophthalmol; 2014 Mar; 14():33. PubMed ID: 24655889
[TBL] [Abstract][Full Text] [Related]
38. Matrix Metalloproteinases and Their Tissue Inhibitors in Blood Serum of Patients with Endometrial Cancer: Clinical and Morphological Correlations.
Gershtein ES; Mushtenko SV; Ermilova VD; Levchenko NE; Kushlinskii NE
Bull Exp Biol Med; 2018 May; 165(1):75-79. PubMed ID: 29796809
[TBL] [Abstract][Full Text] [Related]
39. Matrix metalloproteinase and tissue inhibitor of matrix metalloproteinase expression profiles in tracheal aspirates do not adequately reflect tracheal or lung tissue profiles in neonatal respiratory distress: observations from an animal model.
Miller TL; Touch SM; Shaffer TH
Pediatr Crit Care Med; 2006 Jan; 7(1):63-9. PubMed ID: 16395077
[TBL] [Abstract][Full Text] [Related]
40. Evolution of matrix metalloprotease and tissue inhibitor expression during heart failure progression in the infarcted rat.
Peterson JT; Li H; Dillon L; Bryant JW
Cardiovasc Res; 2000 May; 46(2):307-15. PubMed ID: 10773235
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
